Application Nr Approved Date Route Status External Links
BLA125387 None Intravitreal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Eylea Is Indicated For The Treatment Of: Eylea Is A Vascular Endothelial Growth Factor (vegf) Inhibitor Indicated For The Treatment Of Patients With: Neovascular (wet) Age-Related Macular Degeneration (amd) ( 1.1 ) Macular Edema Following Retinal Vein Occlusion (rvo) ( 1.2 ) Diabetic Macular Edema (dme) ( 1.3 ) Diabetic Retinopathy (dr) ( 1.4 ) 1.1 Neovascular (wet) Age-Related Macular Degeneration (amd) 1.2 Macular Edema Following Retinal Vein Occlusion (rvo) 1.3 Diabetic Macular Edema (dme) 1.4 Diabetic Retinopathy (dr)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Aflibercept

Comments